GO Therapeutics
Cambridge
About GO Therapeutics
GO Therapeutics is the only company with the technologies, platforms and know-how to harness the power of the cancer glycoproteome to generate exceptionally tumor-specific antibodies for cancer immunotherapies. By making antibodies to hybrid antigens combining a tumor’s up-regulated protein expression with a protein’s aberrant glycosylation pattern, we are able to dramatically increase tumor specificity. Our technology clears the hurdles for making drugs that are extremely specific to the cancer cell.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Last round: Undisclosed (Aug 2017)
- Website: gotherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/go-therapeutics-113778 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.